MolsonCoors (TAP) Q3 2025 earnings review
Massive $3.6B Impairment Signals Deeper Woes Than 'Cyclical' Narrative Suggests
Molson Coors reported a weak third quarter, with sales declining 3.3% (constant currency) amid persistent volume pressure. However, the headline was a colossal $3.6 billion non-cash goodwill impairment charge related to its Americas business, resulting in a GAAP loss of $14.79 per share. This accounting move, reflecting a significant reduction in the long-term earnings outlook for its core market, directly challenges the new CEO's narrative that current industry softness is merely cyclical. While underlying EPS of $1.67 was down a more modest 7.2%, the company guided to the low end of its already reduced full-year forecast, implying a weak Q4. New CEO Rahul Goyal is taking immediate action with a restructuring plan, but the scale of the writedown suggests a much tougher road ahead.
🐂 Bull Case
In his first month, new CEO Rahul Goyal has announced a restructuring of the Americas business, aiming to create a leaner organization and reinvest savings. This shows a sense of urgency to address underperformance.
Despite operational headwinds, the company remains committed to its dividend and share repurchase program, having bought back $333 million in stock year-to-date. This signals management's confidence in underlying cash flow.
🐻 Bear Case
The $3.6 billion writedown of the Americas business is a powerful negative signal, implying a permanent deterioration in its long-term cash flow potential. This makes the 'cyclical' weakness explanation less credible.
Guidance was reaffirmed but directed to the 'low end' of the range for key metrics. This implies a deteriorating Q4, with underlying profit expected to decline faster than sales.
⚖️ Verdict: 🔴🔴
Very Bearish. The scale of the goodwill impairment cannot be overstated. It is an admission that the future earnings power of the company's most important segment has been permanently impaired. This action overshadows any operational bright spots or restructuring plans and suggests the company's challenges are more structural than cyclical. The weak guidance for Q4 reinforces this negative outlook.
Key Themes
Data vs. Narrative: $3.6B Impairment Suggests Structural Issues
The single most critical event this quarter was the $3,645.7 million non-cash goodwill impairment for the Americas segment. While this doesn't impact cash flow, it represents a formal acknowledgement that the expected future cash flows from this business are significantly lower than previously believed. This directly contradicts management's public narrative that current industry weakness is merely a 'cyclical' downturn. An impairment of this magnitude points to deeper, structural problems in their core market.
Persistent Volume Declines Across the Business
The top-line pressure continues unabated. Global financial volume fell 6.0% and brand volume fell 4.5%. The core Americas segment saw brand volume fall 4.4% (U.S. down 4.9%), which management attributed to both industry softness and 'lower share performance.' EMEA&APAC brand volume also fell 5.0%. This marks the fourth consecutive quarter of significant volume declines, indicating a persistent problem with consumer demand for their products.
New CEO Moves Swiftly with Restructuring
Rahul Goyal, in the CEO role for only one month, announced a decisive restructuring of the Americas segment. The plan involves eliminating approximately 400 salaried positions (9% of total) to create a 'leaner, more agile organization.' The stated goal is to redeploy savings to invest in key brands, commercial capabilities, and technology, signaling a sense of urgency to address underperformance and pivot towards growth.
Macro Headwinds Cited as Primary Culprit
Management's narrative is that current challenges are external. The earnings call highlighted macro impacts disproportionately affecting 'lower income and Hispanic' consumers in the U.S. and 'continued industry softness' in Europe. They maintain the belief that this weakness is cyclical, positioning the company for a recovery when economic conditions improve. The validity of this external-focused view is now in question following the massive internal writedown.
Focus on Above Premium and Beyond Beer
Despite core challenges, the company is seeing pockets of success in its premiumization strategy. Management highlighted that Peroni volume grew 25% in the quarter. The new CEO also emphasized plans to 'step up our focus on beyond beer,' leveraging partnerships like Fever-Tree, to serve more consumer occasions and find new growth avenues outside of the challenged beer category.
International Profitability Eroding
The EMEA&APAC segment saw underlying pretax income fall 15.1% in constant currency, a much steeper decline than its 2.4% constant currency sales drop. This indicates significant margin pressure from a 'heightened competitive landscape' and soft demand. The challenges facing Molson Coors are global, not isolated to the Americas.
Other KPIs
Stable but declining. Cash flow generation remains a relative strength, down from $856.0 million in the prior year period. This cash generation allows the company to fund its dividend and share repurchase program, providing a floor for shareholder returns despite the sharp drop in GAAP profitability.
Leverage is increasing. Net debt rose from $5.22 billion a year ago. The net debt to underlying EBITDA ratio ticked up to 2.28x from 2.10x in the prior year. While still manageable, the trend is negative, reflecting the pressure on earnings.
Guidance
Decelerating. This is the third consecutive quarter the outlook has been negatively revised or qualified. The move to the 'low end' implies a weak Q4, with management citing lower U.S. distributor inventories and higher Midwest Premium (aluminum) costs.
Decelerating decline. This represents an improvement from the YTD decline of 5.1%, but remains negative. Management expects U.S. shipments to wholesalers to trail retail sales in Q4.
Accelerating decline. This implies a significant deterioration from the YTD decline of 14.9%. The guidance suggests profitability will weaken substantially in Q4, likely due to volume deleverage and rising input costs.